KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Fulgent Genetics (FLGT) Receivables - Other (2017 - 2025)

Fulgent Genetics (FLGT) has disclosed Receivables - Other for 9 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 35.86% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 35.86% year-over-year, with the annual reading at $1.1 million for FY2025, 35.86% down from the prior year.
  • Receivables - Other hit $1.1 million in Q4 2025 for Fulgent Genetics, down from $1.4 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $19.8 million in Q4 2022 to a low of $66000.0 in Q1 2023.
  • Historically, Receivables - Other has averaged $2.2 million across 5 years, with a median of $1.3 million in 2023.
  • Biggest five-year swings in Receivables - Other: soared 8269.62% in 2022 and later tumbled 95.61% in 2023.
  • Year by year, Receivables - Other stood at $237000.0 in 2021, then skyrocketed by 8269.62% to $19.8 million in 2022, then crashed by 93.35% to $1.3 million in 2023, then surged by 34.04% to $1.8 million in 2024, then tumbled by 35.86% to $1.1 million in 2025.
  • Business Quant data shows Receivables - Other for FLGT at $1.1 million in Q4 2025, $1.4 million in Q3 2025, and $2.1 million in Q2 2025.